Dr. Bruce Lahn and his team at VectorBuilder have unveiled a novel mechanism termed occlusis, which elucidates how stem cells differentiate into specialized cell types while progressively losing transcriptional potency. Utilizing a new technique called Potency-Seq, they demonstrated that as stem cells mature, an increasing number of genes become permanently occluded, or silenced, rendering them incapable of expression even in the presence of transcription factors. This research fundamentally shifts our understanding of cell identity, suggesting that the essence of a cell type lies not merely in its expression patterns but in the transcriptional potential of its genome.

The implications of this discovery are profound. By identifying Esrrb as a key deocclusion factor in naïve pluripotent stem cells, the study reveals that these cells can reset their transcriptional landscape, thus maintaining the potential to differentiate into any cell type. This resetting mechanism is critical for understanding how multicellular organisms develop and maintain diverse cell identities. The findings also suggest that occlusis may play a role in the aging process and in diseases like cancer, where errors in differentiation could lead to pathological states.

This research challenges existing paradigms in developmental biology and may accelerate drug development timelines by providing new targets for interventions aimed at reversing or mitigating the effects of occlusis. The establishment of a nonprofit foundation by Dr. Lahn to further explore these mechanisms underscores the need for increased focus on the foundational processes of cell differentiation, which could ultimately lead to innovative therapeutic strategies in regenerative medicine and longevity research.

Source: globenewswire.com